PAT-DX1-NP

N/A

Report date: 2023/11/30 17:53:41

Base Information

Drug NamePAT-DX1-NP
Drug Alias NamePAT-DX1-NP
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDNA repair inhibitorsImmunomodulatorsCell death stimulants
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale UniversityPatrys Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityPatrys Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A